Computational Mapping of Hedgehog Pathway Kinase Module Predicts Node-Specific Craniofacial Phenotypes

Area of Science:

• Developmental Biology
• Molecular Biology
• Computational Biology

Background:

• Craniofacial malformations, including orofacial clefts, affect approximately 1 in 700 births.
• A significant portion (40-60%) of these malformations lack a clear genetic cause and exhibit complex patterns like asymmetry and variable expressivity.
• Classical Sonic Hedgehog (SHH) morphogen gradient models do not fully explain these developmental anomalies.

Purpose of the Study:

• To investigate integrated molecular modules that link morphogen signaling with metabolic stress responses.
• To develop a computational framework for understanding craniofacial developmental outcomes.
• To identify novel candidate genes and pathways involved in craniofacial development.

Main Methods:

• Utilized sequential UniProt gene set integration to identify 186 candidate craniofacial regulators.
• Employed STRING network analysis to reveal modular architecture and molecular docking to profile compound interactions with key proteins (SMO, CK1δ, PINK1, TIE2).
• Reconstructed pathways integrating the SHH-CK1δ-HIF1A-HEY1-PINK1 axis and used a developmental decision tree to map molecular profiles to phenotype hypotheses.

Main Results:

• CK1δ and PINK1 were identified as crucial nodes connecting morphogen signaling with mitochondrial quality control.
• Molecular docking demonstrated preferential binding of compounds to developmental kinases (CK1δ, PINK1) over controls.
• Pathway analysis suggested a mechanism where CK1δ-mediated HIF1A phosphorylation influences downstream gene expression (HEY1, PINK1), and computational hypotheses linked specific nodes to craniofacial defects (e.g., SMO to midline defects, CK1δ to asymmetry).

Conclusions:

• Identified candidate integrated morphogenic modules, perturbed by multiple nodes, that may underlie specific craniofacial malformation patterns.
• Proposed node-phenotype associations as computational hypotheses requiring experimental validation.
• The developed framework could potentially inform developmental toxicity assessments, therapeutic design, and the reclassification of idiopathic craniofacial anomalies.